Status:

COMPLETED

Urinary Cytokines in Patients With Overactive Bladder (OAB)

Lead Sponsor:

The Cleveland Clinic

Collaborating Sponsors:

Astellas Pharma US, Inc.

Conditions:

Overactive Bladder

Urinary Tract Infection

Eligibility:

FEMALE

18+ years

Brief Summary

Overactive bladder (OAB) is a widespread condition characterized by urgency, urge incontinence, nocturia and excessive urinary frequency, affecting millions of people worldwide. In two epidemiological...

Detailed Description

Overactive bladder (OAB) is a widespread condition characterized by urgency, urge incontinence, nocturia and excessive urinary frequency, affecting millions of people worldwide.(1) In two epidemiologi...

Eligibility Criteria

Inclusion

  • Group I (OAB patients)
  • Women with OAB, ≥18 years and premenopausal non-menstruating, not on any anticholinergic for at least two weeks before enrollment in the study.
  • Significant urgency,i.e., having moderate or severe urgency score.
  • Having a score \> 8 on the OAB-V8 questionnaire.
  • Urinary frequency of more than 8/day, with urgency of urination, with or without urge incontinence.
  • Negative screening urinalysis one month after documented UTI.
  • Group II (Control)
  • Age-matched normal volunteers (≥18 years and premenopausal non-menstruating)
  • No Urgency.
  • OAB-8 score \< 8.
  • No UTI.
  • Group III (UTl)
  • Age-matched
  • ≥18 years and premenopausal non-menstruating women with culture proven UTI.

Exclusion

  • Treatable genitourinary conditions that could cause incontinence
  • Hematuria
  • Obstructive uropathy
  • Patients diagnosed with vaginitis
  • History of urothelial carcinoma
  • Urinary tract infection (except group III)
  • Pelvic radiation.
  • Neurogenic bladder.
  • Renal pathology.
  • Stress urinary incontinence.
  • Medications.
  • Recent history of Botox injection in the bladder (Within the last year).

Key Trial Info

Start Date :

March 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00868621

Start Date

March 1 2007

End Date

August 1 2009

Last Update

July 29 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Florida

Weston, Florida, United States, 33331